Minke A.E. Rab

738 total citations
41 papers, 332 citations indexed

About

Minke A.E. Rab is a scholar working on Physiology, Genetics and Hematology. According to data from OpenAlex, Minke A.E. Rab has authored 41 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Physiology, 26 papers in Genetics and 24 papers in Hematology. Recurrent topics in Minke A.E. Rab's work include Erythrocyte Function and Pathophysiology (35 papers), Hemoglobinopathies and Related Disorders (26 papers) and Blood groups and transfusion (14 papers). Minke A.E. Rab is often cited by papers focused on Erythrocyte Function and Pathophysiology (35 papers), Hemoglobinopathies and Related Disorders (26 papers) and Blood groups and transfusion (14 papers). Minke A.E. Rab collaborates with scholars based in Netherlands, United States and Denmark. Minke A.E. Rab's co-authors include Richard van Wijk, Eduard J. van Beers, Brigitte A. van Oirschot, Gerard Pasterkamp, Wouter W. van Solinge, Vivien Sheehan, Penelope A. Kosinski, Charles Kung, Stephanie van Straaten and Lenny Dang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Minke A.E. Rab

37 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minke A.E. Rab Netherlands	9	204	178	158	80	38	41	332
Delphine Lebon France	8	77 0.4×	69 0.4×	108 0.7×	65 0.8×	72 1.9×	42	243
Ruqayyah J. Almizraq Canada	10	197 1.0×	39 0.2×	100 0.6×	95 1.2×	109 2.9×	15	340
Egemen Tütüncüoğlu United States	8	67 0.3×	158 0.9×	131 0.8×	34 0.4×	103 2.7×	18	324
Anthony Cheung United States	5	122 0.6×	359 2.0×	319 2.0×	37 0.5×	63 1.7×	6	441
Paloma Ropero Spain	11	78 0.4×	313 1.8×	262 1.7×	16 0.2×	80 2.1×	85	443
Athinoula Meli United Kingdom	8	86 0.4×	41 0.2×	144 0.9×	40 0.5×	88 2.3×	15	346
SE Graber United States	6	123 0.6×	89 0.5×	272 1.7×	32 0.4×	54 1.4×	8	353
Francesca La Carpia United States	8	54 0.3×	48 0.3×	62 0.4×	18 0.2×	124 3.3×	15	281
Valentina Brancaleoni Italy	12	57 0.3×	186 1.0×	167 1.1×	68 0.8×	240 6.3×	38	457
Emilsé Bermejo Argentina	10	46 0.2×	42 0.2×	92 0.6×	18 0.2×	29 0.8×	23	214

Countries citing papers authored by Minke A.E. Rab

Since Specialization

Citations

This map shows the geographic impact of Minke A.E. Rab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minke A.E. Rab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minke A.E. Rab more than expected).

Fields of papers citing papers by Minke A.E. Rab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minke A.E. Rab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minke A.E. Rab. The network helps show where Minke A.E. Rab may publish in the future.

Co-authorship network of co-authors of Minke A.E. Rab

This figure shows the co-authorship network connecting the top 25 collaborators of Minke A.E. Rab. A scholar is included among the top collaborators of Minke A.E. Rab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minke A.E. Rab. Minke A.E. Rab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oirschot, Brigitte A. van, Judith Jans, Megan Wind‐Rotolo, et al.. (2025). Ex vivo activation of pyruvate kinase improves red blood cell metabolism and hydration in hereditary spherocytosis. 1(1). 100005–100005.

Levine, Charles, Anita W. Rijneveld, Judith Jans, et al.. (2025). Red blood cell pyruvate kinase properties in Townes and Berkeley sickle cell disease mouse models – Of mice and men. Blood Cells Molecules and Diseases. 111. 102909–102909.

Oirschot, Brigitte A. van, Judith Jans, Wouter W. van Solinge, et al.. (2025). Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease. American Journal of Hematology. 100(5). 785–796. 2 indexed citations

Hakonen, Anna H., Ulla Wartiovaara‐Kautto, Sakari Kakko, et al.. (2024). Biallelic hexokinase 1 (HK1) variants causative of non‐spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review. British Journal of Haematology. 204(5). 2040–2048.

Beers, Eduard J. van, Richard van Wijk, Evelyn Groot, et al.. (2024). Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II - Results from the 8-Week Dose-Escalation Period. Blood. 144(Supplement 1). 3831–3831. 1 indexed citations

Oirschot, Brigitte A. van, Wouter W. van Solinge, Margaret James Koziel, et al.. (2024). A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease. SHILAP Revista de lepidopterología. 5(1). 21–32. 1 indexed citations

Rab, Minke A.E., Brigitte A. van Oirschot, Anita W. Rijneveld, et al.. (2024). Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease. HemaSphere. 8(6). e109–e109. 1 indexed citations

Rab, Minke A.E., Brigitte A. van Oirschot, Anita W. Rijneveld, et al.. (2023). One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study. Blood Advances. 7(24). 7539–7550. 8 indexed citations

Rab, Minke A.E., Camille Boisson, Brigitte A. van Oirschot, et al.. (2023). Oxygen gradient ektacytometry–derived biomarkers are associated with acute complications in sickle cell disease. Blood Advances. 8(2). 276–286. 5 indexed citations

10.

Solinge, Wouter W. van, Eduard J. van Beers, Marije Bartels, et al.. (2023). Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic Tests. Blood. 142(Supplement 1). 2453–2453. 1 indexed citations

11.

Darras, Alexis, Thomas John, Greta Simionato, et al.. (2023). Effect of Cell Age and Membrane Rigidity on Red Blood Cell Shape in Capillary Flow. Cells. 12(11). 1529–1529. 7 indexed citations

12.

Jans, Judith, Lenny Dang, Megan Wind‐Rotolo, et al.. (2023). P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES. HemaSphere. 7(S3). e59102e2–e59102e2. 2 indexed citations

13.

Boisson, Camille, Céline Renoux, Élie Nader, et al.. (2021). Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without α‐thalassaemia. British Journal of Haematology. 195(4). 629–633. 3 indexed citations

14.

Huisjes, Rick, Brigitte A. van Oirschot, Wouter W. van Solinge, et al.. (2021). Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis. Frontiers in Physiology. 12. 641384–641384. 8 indexed citations

15.

Rab, Minke A.E., Brigitte A. van Oirschot, Evelyn Kendall Williams, et al.. (2021). Use of Red Blood Cell Phenotypes for Second Line Therapy Selection in Sickle Cell Disease. Blood. 138(Supplement 1). 2053–2053. 1 indexed citations

16.

Schmidt, David E., Minke A.E. Rab, Bob Meek, et al.. (2021). A functional spleen contributes to afucosylated IgG in humans. Scientific Reports. 11(1). 24045–24045. 6 indexed citations

17.

Rab, Minke A.E., Brigitte A. van Oirschot, Penelope A. Kosinski, et al.. (2020). AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes. Haematologica. 106(1). 238–249. 54 indexed citations

18.

Rab, Minke A.E., et al.. (2019). Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry. Journal of Visualized Experiments. 11 indexed citations

19.

Rab, Minke A.E., Brigitte A. van Oirschot, Stephanie van Straaten, et al.. (2019). Decreased Activity and Stability of Pyruvate Kinase in Hereditary Hemolytic Anemia: A Potential Target for Therapy By AG-348 (Mitapivat), an Allosteric Activator of Red Blood Cell Pyruvate Kinase. Blood. 134(Supplement_1). 3506–3506. 12 indexed citations

20.

Rab, Minke A.E., A. Meerveld-Eggink, Heleen van Velzen‐Blad, et al.. (2017). Persistent changes in circulating white blood cell populations after splenectomy. International Journal of Hematology. 107(2). 157–165. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact